A prospective cohort study investigating the association between type 2 diabetes and subsequent cardiovascular events in patients with different blood pressure, HbA1c, and lipid levels

Yan Zhang,Nianchun Peng,Danrong Wu,Miao Zhang,Qiao Zhang,Lixin Shi
DOI: https://doi.org/10.5603/ep.101090
2024-10-31
Endokrynologia Polska
Abstract:Background: Globally, there has been a steady increase in the prevalence of type 2 diabetes, and the risk of cardiovascular disease has increased. The relationship between diabetes and the incidence of cardiovascular disease (CVD) at different blood pressure, glycated haemoglobin A 1c (HbA 1c ), and lipid levels remains uncertain. This study aimed to investigate these associations within a population-based cohort. Material and methods: We analysed data from the Guiyang subcentre of the China Cardiometabolic Disease and Cancer Cohort Study, which enrolled participants aged 40 years and older between 2011 and 2012. Subsequently, a follow-up visit was conducted during 2014–2016 to assess incident CVD events. Results: The analysis included a cohort of 7197 adults, of whom 590 were diagnosed with diabetes. Among all the participants, the CVD events linked to diabetes had a multivariable adjusted hazard ratio of 2.37 [95% confidence intervals (CI): 1.38–4.08]. Patients with diabetes had a greater risk of experiencing CVD events if they had high blood pressure [hazard ratios (HR): 1.24, 95% CI: 1.39–4.21] and high lipid levels (HR: 2.19, 95% CI: 1.29–3.70) compared to people with normal blood pressure (HR: 1.23, 95% CI: 0.54–2.82) and lipid levels (HR: 1.26, 95% CI: 0.47–3.41). Conclusions: Our analysis revealed a significant association between diabetes and an increased risk of subsequent CVD events, which can be mitigated through optimal management of the metabolic profile of cardiovascular risk factors.
endocrinology & metabolism
What problem does this paper attempt to address?